Previous studies have reported that SLC2A1 is highly expressed in a variety of cancers, such as BLCA, LUAD, LIHC, CESC, COAD, OV, UCEC, BRCA, STAD, ESCA, and PAAD [11,12,13,14,15,31,32,33,34,35,36,37]. The gene discussed is SLC2A1; the disease is cancer.